Genomics & Health Impact Scan Database|Weekly Scan|PHGKB
Publication Date: Mar 9, 2017
About the Genomics & Health Impact Weekly Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span, including, birth defects, newborn screening, reproductive health, childhood diseases, cancer, chronic diseases, pharmacogenomics, family health history, guidelines and recommendations. The weekly sweep also includes news, reviews, commentaries, tools and databases.
Human Genomics across the Lifespan
Birth Defects and Child Health
Cancer
- Screening for Lynch Syndrome,
6abc, March 2, 2017
- BRCA And Me: The Impact Of Screening High-Risk Women Against Ovarian Cancer
C Presho, Huffington Post, March 2017
- Few people actually benefit from breakthrough cancer immunotherapy
Stat News, March 2017
- Colorectal Cancer Incidence Patterns in the United States, 19742013
Siegel RL, et al. J Natl Cancer Inst (2017) 109 (8): djw322.
- Advanced Cancer Treatments Far From Big-Name Hospitals Precision medicine should become more widely available, and fewer patients will need to travel far for care
E Kincaid, WSJ, March 6, 2017
- Realizing the Potential of Cancer Prevention The Role of Implementation Science
KM Emmons et al, NEJM, March 8, 2017
- Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review.
Prince Anya E R et al. Pharmacogenomics and personalized medicine 2017 1049-60
- Colorectal cancer rates rising sharply among Gen X and millennials,
by Laurie McGinley, Washington Post, February 28, 2017
- Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions
Agustín González-Reymúndez et al, Eur J Human Genetics, March 8, 2017
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).
Duffy M J et al. European journal of cancer (Oxford, England : 1990) 2017 Feb 75284-298
- Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.
Leroy Bernard et al. Cancer research 2017 Mar
- Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
Armstrong Katrina et al. Cancer 2016 122(9) 1338-42
- Noninvasive strategies for lung cancer testing
NIH Research Matters, March 7, 2017
Disclaimer: Articles listed in Health Impact Weekly Scan are selected by the CDC Office of Public Health Genomics to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
No hay comentarios:
Publicar un comentario